In Alzheimer’s disease (AD), C/EBPβ drives tau cleavage and Aβ pathology through the AEP axis and exacerbates neuroinflammation by upregulating APOE4. Here, CEBPB is linked to early-onset autosomal dominant Alzheimer disease.